Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer

10 Jan 2025

Abstract excerpt

Background Bladder cancer (BCa) is one of the most common malignancies worldwide, and its prognostication and treatment remains challenging. The fast growth of various cancer cells requires reprogramming of its energy metabolism using aerobic glycolysis as a major energy source. However, the prognostic and therapeutic value of glycolysis-related genes in BCa remains to be determined. Methods The fused merge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39867879
DOI: 10.3389/fimmu.2024.1430583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancerPMID 39867879Read ↗

Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.Semantic proximity Read ↗

Identifying novel cell glycolysis related gene signature predictive of overall survival in bladder urothelial carcinomaSemantic proximity Read ↗

A Five-Gene Stromal-EMT Signature Predicts Prognosis, Immunotherapy Resistance, and Therapeutic Vulnerability in Bladder CancerSemantic proximity Read ↗

Development and validation of a exosome-related gene signature for predicting prognosis, immune infiltration and immunotherapeutic response in bladder cancerSemantic proximity Read ↗

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancerSemantic proximity Read ↗

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancerSemantic proximity Read ↗

Metabolic-Associated Signature and Hub Genes Associated with Immune Microenvironment and Prognosis in Bladder CancerSemantic proximity Read ↗

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancerSemantic proximity Read ↗

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancerSemantic proximity Read ↗

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancerSemantic proximity Read ↗

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCASemantic proximity Read ↗

Machine learning prediction models based on hub genes related to immune phenotypes in muscle-invasive bladder cancer treated with immune checkpoint blockadeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.